Prevalence of and Factors Associated with Malignancy in Males with Iron-Deficiency Anemia.
- Author:
Byung Hyun LEE
1
;
Jae Joong LEE
;
Jae Kyeom SIM
;
Jung Sun KIM
;
Dae Sik KIM
;
Seh Jong PARK
;
Se Ryeon LEE
;
Yong PARK
;
Chul Won CHOI
;
Byung Soo KIM
Author Information
1. Department of Internal Medicine, Korea University Medical Center, Seoul, Korea. bonnie@korea.ac.kr
- Publication Type:Original Article
- Keywords:
Anemia, Iron-Deficiency;
Male;
Neoplasms;
Prevalence
- MeSH:
Anemia;
Anemia, Iron-Deficiency*;
Colorectal Neoplasms;
Hemorrhage;
Humans;
Iron;
Korea;
Male;
Mass Screening;
Occult Blood;
Prevalence*;
Retrospective Studies;
Risk Factors
- From:Korean Journal of Medicine
2014;87(1):53-60
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: Despite several reports on clinical aspects of anemia and malignancy, little is known of male patients with iron-deficiency anemia (IDA) and malignancy in Korea. We examined the cause of anemia, prevalence of and factors associated with malignancy, and treatment response to iron therapy in male IDA patients. METHODS: The results of 202 males with IDA seen from March 2008 to June 2013 were analyzed retrospectively. The patients were divided into two groups based on the causes of anemia: the cancer group included patients with anemia caused by malignancy and the non-cancer group included patients with anemia due to other causes. We compared the clinical characteristics and response to iron therapy between the two groups. RESULTS: The most common cause of IDA was bleeding (42.6%). The prevalence of malignancy was 11.9%, with colorectal cancer (58.3%) being the most common. Among the cancer patients (n = 24), 22 patients (91.7%) were age 50 or older. Independent factors associated with malignancy were old age (OR, 1.05; p = 0.026) and a positive stool occult blood test (OR, 7.48; p = 0.001). The treatment response to iron therapy based on a normalized hemoglobin level was lower in the cancer group (OR, 0.49; p = 0.31), but the difference did not reach statistical significance. The treatment response based on the mean hemoglobin level was significantly lower in the cancer group (12.6 +/- 2.2 vs. 13.8 +/- 1.6 g/dL, p = 0.016). CONCLUSIONS: Old age and a positive stool occult blood test were independent risk factors for malignancy in male IDA patients. We recommend screening for malignancy in patients older than 50 years or with a positive stool occult blood test.
